Poseida Therapeutics Inc PSTX

Buzz on the Bullboards: Stocks to watch in volatile times.

[PressRelease]

NEW YORK, Dec. 3, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:Poseida Therapeutics, Inc. (NASDAQ: PSTX)'s sale...read article.

[Jonathon Brown]

The TSX hit another record high on strong retail sales data and positive investor sentiment. However, the index quickly fell from grace. read article.

[PressRelease]

NEW YORK, Nov. 27, 2024 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm by ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York...read article.

[PressRelease]

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Poseida Therapeutics, Inc. (NasdaqGS: PSTX) to Roche Holdings, Inc. Under the terms of the proposed transaction, shareholders of Poseida will...read article.

[BalanceBeam17y8]

$PSTX gets scooped up by Roche in a $1.5B deal, marking another major acquisition in biotech. The move reflects growing confidence in the sector. $MYNZ also gained 8% yesterday, following the sector’s

[TrendCaster8w8w]

Big news in biotech as Roche acquires $PSTX, valuing the deal at $1.5B. This highlights strong interest in innovative players. Meanwhile, $MYNZ rose 8% yesterday, riding the wave of optimism in the

[whytestocks]

Breaking News: $PSTX Poseida Therapeutics, Inc. Announces Agreement to be Acquired by Roche Holdings, Inc.Poseida Therapeutics, Inc. Announces Agreement to be Acquired by Roche Holdings, Inc. PR

[ZenithEquity89]

$PSTX gets scooped up by Roche in a $1.5B acquisition, pricing shares near $9. This highlights the value of innovation in the space. $MYNZ, with its advanced test tech, might also attract M&A

[ProfitGrid8448]

Big news for $PSTX—Roche is acquiring the company in a $1.5B deal, valuing shares at nearly $9 each. A solid premium for investors. With its cutting-edge test developments, $MYNZ could be another

[MikeTester]

https://beyondspx.com/2024/08/02/poseida-therapeutics-inc-nasdaqpstx-a-promising-biotech-poised-for-growth/

[askretka]

Stock seems to be up they are presenting a Late Breaking abstract at upcoming CAR-T summit. Anyone know anything else about this one?